Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Total Non-Current Liabilities (2022 - 2025)

Historic Total Non-Current Liabilities for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $60.8 million.

  • Orchestra BioMed Holdings' Total Non-Current Liabilities changed N/A to $60.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.8 million, marking a year-over-year change of. This contributed to the annual value of $43.2 million for FY2024, which is N/A changed from last year.
  • Orchestra BioMed Holdings' Total Non-Current Liabilities amounted to $60.8 million in Q3 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Total Non-Current Liabilities ranged from a high of $60.8 million in Q3 2025 and a low of $34.2 million during Q1 2023
  • For the 4-year period, Orchestra BioMed Holdings' Total Non-Current Liabilities averaged around $42.0 million, with its median value being $41.5 million (2022).